The Delhi High Court denied relief to Ram Singh, accused of duping a woman of Rs.12 crore by selling a fake DLF Camellias flat. The Court said he appeared the key conspirator and principal facilitator in the case.
The Delhi High Court directed Dr Reddy’s Laboratories to stop selling or expanding its diabetes drug “Olymviq,” citing phonetic similarity with Novo Nordisk’s “Ozempic.” Justice Jyoti Singh noted such similarity in pharma crosses an unacceptable threshold, indicating prima facie trademark infringement.
